Advertisement

Aquaculture International

, Volume 27, Issue 6, pp 1825–1834 | Cite as

Dietary β-1,3/1,6-glucans improve the effect of a multivalent vaccine in Atlantic salmon infected with Moritella viscosa or infectious salmon anemia virus

  • Fernando de O. Roberti Filho
  • João Fernando Albers Koch
  • Christian Wallace
  • Miguel Costa LealEmail author
Article
  • 27 Downloads

Abstract

The immunomodulatory properties of β-glucans are well documented for several animal species. However, little is known on their use as enhancers of non-specific and specific responses against Moritella viscosa and infectious salmon anemia (ISA) virus, which are two major pathogens affecting the Atlantic salmon aquaculture industry. The present study assessed the effects of dietary β-1,3/1,6-glucans (MacroGard®) and vaccination on the survival of Atlantic salmon (Salmo salar) post-smolts challenged with M. viscosa or ISA virus. Dietary supplementation decreased mortality in both unvaccinated (55.4%; RPSend 19.9) and vaccinated (9.3%; RPSend 86.6) M. viscosa-challenged fish compared to the non-supplemented groups (69.1% and 28.3% mortality in unvaccinated and vaccinated fish, respectively; RPSend 59 for vaccinate non-supplemented fish). Similarly, mortality of ISA virus-challenged fish decreased from 87.5% in vaccinated fish without supplementation (RPSend 9.2) to 70.9% in the supplemented and vaccinated group (RPSend 26.4). In summary, these findings show that dietary β-glucans increase Atlantic salmon resistance and improve the protective effect of vaccines against the tested pathogens.

Keywords

Atlantic salmon Vaccination Glucans Winter ulcer disease ISA virus 

Notes

Acknowledgments

The authors would like to thank Biorigin for intellectual support, and for providing the β-glucan supplements.

Funding information

Biorigin provided financial support. MC Leal was funded by the Portuguese Science Foundation (SFRH/BPD/115298/2016).

Compliance with ethical standards

Conflict of interest

Fernando Roberti Filho and João Albers Koch are both employed by Biorigin Company, and Christian Wallace is employed by VESO Vikan. Miguel Costa Leal has received a research grant from Fundação para a Ciência e Tecnologia (Portugal).

Ethical approval

All applicable international, national, and institutional guidelines for the care and use of animals were followed by the authors.

References

  1. Aguilar J, Rodriguez E (2007) Vaccine adjuvants revisited. Vaccine 25:3752–3762CrossRefGoogle Scholar
  2. Amend DF (1981) Potency testing of fish vaccines. Dev Biol Stand 49:447–454Google Scholar
  3. Asche F, Cojocaru AL, Roth B (2016) The development of large scale aquaculture production: a comparison of the supply chains for chicken and salmon. Aquaculture 493:446–455CrossRefGoogle Scholar
  4. Bouchard D, Keleher W, Opitz HM, Blake S, Edwards KC, Nicholson BL (1999) Isolation of infectious salmon anemia virus (ISAV) from Atlantic salmon in New Brunswick, Canada. Dis Aquat Org 35:131–137CrossRefGoogle Scholar
  5. Bridle AR, Carter CG, Morrison RN, Nowak BF (2005) The effect of β-glucan administration on macrophage respiratory burst activity and Atlantic salmon, Salmo salar L., challenged with amoebic gill disease – evidence of inherent resistance. J Fish Dis 28:347–356CrossRefGoogle Scholar
  6. Diao J, Ye H-b, Yu X-q, Fan Y, Xu L, Li T-b, Wang Y-q (2013) Adjuvant and immunostimulatory effects of LPS and β-glucan on immune response in Japanese flounder, Paralichthys olivaceus. Vet Immunol Immunopathol 156:167–175CrossRefGoogle Scholar
  7. Engstad RE, Robertsen B (1995) Effects of structurally different yeast β-glucans on immune responses in Atlantic salmon (Salmo salar). J Mar Biotechnol 3:203–207Google Scholar
  8. Falk K (2014) Vaccination against infectious salmon anemia. In: Gudding R, Lillehaug A, Evensen Ø (eds) Fish vaccination. John Wiley & Sons, Ltd, Chichester, pp 313–320CrossRefGoogle Scholar
  9. Falk K, Namork E, Rimstad E, Mjaaland S, Dannvig BH (1997) Characterization of infectious salmon anemia virus, an orthomyxo-like virus isolated from Atlantic Salmon (Salmo salar L.). J Virol 71:9016–9023PubMedPubMedCentralGoogle Scholar
  10. Falk K, Namork E, Dannvig BH (1998) Characterization and applications of a monoclonal antibody against infectious salmon anaemia virus. Dis Aquat Org 34:77–85CrossRefGoogle Scholar
  11. Food and Agriculture Organization (2016) The State of World Fisheries and Aquaculture 2016. Contributing to food security and nutrition for all. Pages 200 in FAO editor. RomeGoogle Scholar
  12. Gomez-Casado E, Estepa A, Coll J (2011) A comparative review on European-farmed finfish RNA viruses and their vaccines. Vaccine 29:2657–2671CrossRefGoogle Scholar
  13. Gudmundsdóttir BK, Bjornsdóttir B (2007) Vaccination against atypical furunculosis and winter ulcer disease of fish. Vaccine 25:5512–5523CrossRefGoogle Scholar
  14. Jones SR, Bruno DW, Madsen L, Peeler EJ (2015) Disease management mitigates risk of pathogen transmission from maricultured salmonids. Aquac Environ Interact 6:119–134CrossRefGoogle Scholar
  15. Jørgensen SM, Afanasyev S, Krasnov A (2008) Gene expression analyses in Atlantic salmon challenged with infectious salmon anemia virus reveal differences between individuals with early, intermediate and late mortality. BMC Genomics 9:1–16CrossRefGoogle Scholar
  16. Karlsen C, Thorarinsson R, Wallace C, Salonius K, Midtlyng PJ (2017) Atlantic salmon winter-ulcer disease: combining mortality and skin ulcer development as clinical efficacy criteria against Moritella viscosa infection. Aquaculture 473:538–544CrossRefGoogle Scholar
  17. Kent ML, Feist SW, Harper C, Hoogstraten-Miller S, Mac Law J, Sanchez-Morgado JM, Tanguay RL, Sanders GE, Spitsbergen JM, Whipps CM (2009) Recommendations for control of pathogens and infectious diseases in fish research facilities. Comp Biochem Physiol Part C: Toxicol Pharmacol 149:240–248Google Scholar
  18. Kolarevic J, Baeverfjord G, Takle H, Ytteborg E, Reiten BKM, Nergård S, Terjesen BF (2014) Performance and welfare of Atlantic salmon smolt reared in recirculating or flow through aquaculture systems. Aquaculture 432:15–25CrossRefGoogle Scholar
  19. Lafferty KD, Harvell CD, Conrad JM, Friedman CS, Kent ML, Kuris AM, Powell EN, Rondeau D, Saksida SM (2015) Infectious diseases affect marine fisheries and aquaculture economics. Annu Rev Mar Sci 7:471–496CrossRefGoogle Scholar
  20. Løvoll M, Wiik-Nielsen CR, Tunsjø HS, Colquhoun D, Lunder T, Sørum H, Grove S (2009) Atlantic salmon bath challenged with Moritella viscosa – pathogen invasion and host response. Fish Shellfish Immunol 26:877–884CrossRefGoogle Scholar
  21. Lunder T, Evensen Ø, Holstad G, Håstein T (1995) Winter ulcer' in the Atlantic salmon Salmo salar. Pathological and bacteriological investigations and transmission experiments. Dis Aquat Org 23:39–49CrossRefGoogle Scholar
  22. Meena DK, Das P, Kumar S, Mandal SC, Prusty AK, Singh SK, Akhtar MS, Behera BK, Kumar K, Pal AK, Mukherjee SC (2013) Beta-glucan: an ideal immunostimulant in aquaculture (a review). Fish Physiol Biochem 39:431–457CrossRefGoogle Scholar
  23. Nayak S (2010) Probiotics and immunity: a fish perspective. Fish Shellfish Immunol 29:2–14CrossRefGoogle Scholar
  24. Paulsen SM, Engstad RE, Robertsen B (2001) Enhanced lysozyme production in Atlantic salmon (Salmo salar L.) macrophages treated with yeast β-glucan and bacterial lipopolysaccharide. Fish Shellfish Immunol 11:23–37CrossRefGoogle Scholar
  25. Petit J, Wiegertjes GF (2016) Long-lived effects of administering b-glucans: indications for trained immunity in fish. Dev Comp Immunol 64:93–102CrossRefGoogle Scholar
  26. Pettersen JM, Osmundsen T, Aunsmo A, Mardones FO, Rich KM (2015) Controlling emerging infectious diseases in salmon aquaculture. Rev Sci Tech 34:923–938CrossRefGoogle Scholar
  27. Pilarski F, de Oliveira CAF, de Souza FPBD, Zanuzzo FS (2017) Different β-glucans improve the growth performance and bacterial resistance in Nile tilapia. Fish Shellfish Immunol 70:25–29CrossRefGoogle Scholar
  28. Refstie S, Baeverfjord G, Seim RR, Elvebø O (2010) Effects of dietary yeast cell wall β-glucans and MOS on performance, gut health, and salmon lice resistance in Atlantic salmon (Salmo salar) fed sunflower and soybean meal. Aquaculture 305:109–116CrossRefGoogle Scholar
  29. Ringø E, Olsen RE, Jensen I, Romero J, Lauzon HL (2014) Application of vaccines and dietary supplements in aquaculture: possibilities and challenges. Rev Fish Biol Fish 24:1005–1032CrossRefGoogle Scholar
  30. Robertsen B, Rørstad G, Engstad R, Raa J (1990) Enhancement of non-specific disease resistance in Atlantic salmon, Salmo salar L., by a glucan from Saccharomyces cerevisiae cell walls. J Fish Dis 13:391–400CrossRefGoogle Scholar
  31. Rodger HD (2016) Fish disease causing economic impact in global aquaculture. Pages 34. In: Fish vaccines. SpringerGoogle Scholar
  32. Rodríguez FE, Valenzuela B, Farías A, Sandino AM, Imarai M (2016) β-1, 3/1, 6-glucan-supplemented diets antagonize immune inhibitory effects of hypoxia and enhance the immune response to a model vaccine. Fish Shellfish Immunol 59:36–45CrossRefGoogle Scholar
  33. Rørstad G, Aasjord PM, Robertsen B (1993) Adjuvant effect of a yeast glucan in vaccines against furunculosis in Atlantic salmon (Salmo salar L.). Fish Shellfish Immunol 3:179–190CrossRefGoogle Scholar
  34. Soltanian S, Stuyven E, Cox E, Sorgeloos P, Bossier P (2009) Beta-glucans as immunostimulant in vertebrates and invertebrates. Crit Rev Microbiol 35:109–138CrossRefGoogle Scholar
  35. Tafalla C, Bøgwald J, Dalmo RA (2013) Adjuvants and immunostimulants in fish vaccines: current knowledge and future perspectives. Fish Shellfish Immunol 35:1740–1750CrossRefGoogle Scholar
  36. Thorarensen H, Farrell AP (2011) The biological requirements for post-smolt Atlantic salmon in closed-containment systems. Aquaculture 312:1–14CrossRefGoogle Scholar
  37. Vallejos-Vidal E, Reyes-López F, Teles M, MacKenzie S (2016) The response of fish to immunostimulant diets. Fish shellfish Immunol 56:34–69CrossRefGoogle Scholar
  38. Verlhac V, Obach A, Gabaudan J, Schüep W, Hole R (1998) Immunomodulation by dietary vitamin C and glucan in rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol 8:409–424CrossRefGoogle Scholar
  39. Vetvicka V, Vannucci L, Sima P (2013) The effects of B-glucan on fish immunity. N Am J Med Sci 5:580–588CrossRefGoogle Scholar
  40. World Organisation for Animal Health (2017) OIE-listed diseases, infections and infestations in force in 2017. Available at: www.oie.int/animal-health-in-the-world/oie-listed-diseases-2017/. Accessed 15 Oct 2017

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Biorigin CompanySao PauloBrazil
  2. 2.VESO Vikan, Aquamedical Contract ResearchNamsosNorway
  3. 3.MARE–Marine and Environmental Sciences Centre, Faculty of SciencesUniversity of LisbonLisbonPortugal

Personalised recommendations